Hepatitis B


Hepatitis B is an infectious liver inflammation, triggered by the hepatitis B virus. Transmission occurs through contact with bodily fluids of infected persons. The majority will rapidly and spontaneously recover from the acute inflammation. Vaccination against hepatits B is recommended.

Pathogens and transmission

Hepatitis B is an infectious liver inflammation that is triggered by the hepatitis B virus. The highly infectious hepatitis B virus is transmitted through contact with bodily fluids (especially blood and genital secretions) of infected persons, namely by sharing injection syringes and from intercourse (genital, anal, oral), but also from small lesions of the skin or through the mucous membrane. Infected mothers can transmit the disease to their child during childbirth.

Clinical picture

The clinical progress is very varied. The disease progresses without symptoms in about one-third of patients. In the classical form of hepatitis B, non-specific general symptoms such as loss of appetite, nausea, vomiting, stomach pains, sometimes also painful joints, fever and a skin rash may appear 45 to 180 days after infection. In most cases there is a spontaneous full recovery. However, less than 5 percent of persons who become infected as adults, but 90 percent of babies who are infected at birth develop chronic hepatitis B, which can lead to cirrhosis of the liver or to liver cancer. A chronic infection can be treated with antiviral drugs.

Frequency and distribution

Hepatitis B occurs worldwide, but particularly in Asian countries, the Middle East, Africa as well as parts of the Americas. In Switzerland, about 0.5 percent of the population are infected with the hepatitis B virus, while worldwide figures average around 3.5 percent. Around 40 cases of acute hepatitis B are notified per year in Switzerland, with a downward trend. Men are much more affected by acute hepatitis B; they make up about 75 percent of cases. The age group 35-60 years makes up the majority of cases (roughly 55 percent).


Vaccination against hepatitis B is primarily recommended for infants by using a hexavalent combination vaccine at the age of 2, 4 and 12 months. Vaccination at the age between 11 and 15 years is equally recommended for adolescents not yet vaccinated against hepatitis B as well as for certain risk groups, e.g. for health care professionals and drug users.

The risk of an infection can be reduced by avoiding the sharing of syringes and being tattooed in countries with a high prevalence of hepatitis B.

If you have changing or multiple sexual partners during the same time period, talk to your doctor or another specialist about sexually transmitted infections (including HIV) and get advice on whether tests may be necessary.

In case of an infection, www.lovelife.ch provides tips on how to inform your partner.

And for everyone having sex:

Do your Safer Sex Check at www.lovelife.ch!

If you’re pregnant, be sure to have regular check-ups with your gynaecologist, too. Pregnant women are tested for HIV, syphilis, hepatitis B and more to help protect the unborn child.


Last modification 22.04.2024

Top of page


Federal Office of Public Health FOPH
Division Communicable diseases
Schwarzenburgstrasse 157
3003 Bern
Tel. +41 58 463 87 06

Print contact